JP2021530232A5 - - Google Patents

Info

Publication number
JP2021530232A5
JP2021530232A5 JP2021502525A JP2021502525A JP2021530232A5 JP 2021530232 A5 JP2021530232 A5 JP 2021530232A5 JP 2021502525 A JP2021502525 A JP 2021502525A JP 2021502525 A JP2021502525 A JP 2021502525A JP 2021530232 A5 JP2021530232 A5 JP 2021530232A5
Authority
JP
Japan
Prior art keywords
gene
optionally
cells
protein
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021502525A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021530232A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/042117 external-priority patent/WO2020018615A2/en
Publication of JP2021530232A publication Critical patent/JP2021530232A/ja
Publication of JP2021530232A5 publication Critical patent/JP2021530232A5/ja
Priority to JP2024001947A priority Critical patent/JP2024050597A/ja
Pending legal-status Critical Current

Links

JP2021502525A 2018-07-17 2019-07-17 免疫改変された多能性細胞から分化させた細胞 Pending JP2021530232A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024001947A JP2024050597A (ja) 2018-07-17 2024-01-10 免疫改変された多能性細胞から分化させた細胞

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
US201862698973P 2018-07-17 2018-07-17
US201862698984P 2018-07-17 2018-07-17
US201862698978P 2018-07-17 2018-07-17
US201862698965P 2018-07-17 2018-07-17
US201862698981P 2018-07-17 2018-07-17
US62/698,973 2018-07-17
US62/698,981 2018-07-17
US62/698,984 2018-07-17
US62/698,965 2018-07-17
US62/698,978 2018-07-17
PCT/US2019/042117 WO2020018615A2 (en) 2018-07-17 2019-07-17 Cells differentiated from immunoengineered pluripotent cells

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024001947A Division JP2024050597A (ja) 2018-07-17 2024-01-10 免疫改変された多能性細胞から分化させた細胞

Publications (2)

Publication Number Publication Date
JP2021530232A JP2021530232A (ja) 2021-11-11
JP2021530232A5 true JP2021530232A5 (https=) 2022-08-09

Family

ID=69165113

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021502525A Pending JP2021530232A (ja) 2018-07-17 2019-07-17 免疫改変された多能性細胞から分化させた細胞
JP2024001947A Pending JP2024050597A (ja) 2018-07-17 2024-01-10 免疫改変された多能性細胞から分化させた細胞

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024001947A Pending JP2024050597A (ja) 2018-07-17 2024-01-10 免疫改変された多能性細胞から分化させた細胞

Country Status (12)

Country Link
US (2) US20210292715A1 (https=)
EP (1) EP3824074A4 (https=)
JP (2) JP2021530232A (https=)
KR (1) KR20210032454A (https=)
CN (2) CN112639079A (https=)
AU (2) AU2019305585A1 (https=)
BR (1) BR112021000637A2 (https=)
CA (1) CA3109078A1 (https=)
IL (2) IL314721A (https=)
MX (2) MX2021000614A (https=)
SG (1) SG11202100157YA (https=)
WO (1) WO2020018615A2 (https=)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019189640A1 (ja) * 2018-03-28 2019-10-03 国立大学法人大阪大学 幹細胞由来涙腺組織の作製方法
CA3109078A1 (en) * 2018-07-17 2020-01-23 The Regents Of The University Of California Cells differentiated from immunoengineered pluripotent cells
US11162079B2 (en) 2019-05-10 2021-11-02 The Regents Of The University Of California Blood type O Rh-hypo-immunogenic pluripotent cells
US12221622B2 (en) 2019-05-10 2025-02-11 The Regents Of The University Of California Modified pluripotent cells
GB2584664B (en) * 2019-06-10 2023-05-24 Newcells Biotech Ltd Improved retinal organoids and methods of making the same
JP7728747B2 (ja) 2019-08-23 2025-08-25 サナ バイオテクノロジー，インコーポレイテッド Ｃｄ２４発現細胞およびそれらの用途
WO2021146222A1 (en) * 2020-01-13 2021-07-22 Sana Biotechnology, Inc. Modification of blood type antigens
WO2021146471A2 (en) * 2020-01-15 2021-07-22 The Regents Of The University Of California Transplanted cell protection via inhibition of polymorphonuclear cells
KR20220158046A (ko) * 2020-03-25 2022-11-29 사나 바이오테크놀로지, 인크. 신경계 장애 및 병태의 치료를 위한 면역저하성 신경 세포
AU2021262766A1 (en) * 2020-04-27 2022-11-24 Sana Biotechnology, Inc. Repeat dosing of hypoimmunogenic cells
EP4149525A4 (en) * 2020-05-15 2024-08-28 Rxcell Inc. HYPOIMMUNOGENIC CELLS AND THEIR USES IN IMMUNE RESPONSES
WO2022036150A1 (en) 2020-08-13 2022-02-17 Sana Biotechnology, Inc. Methods of treating sensitized patients with hypoimmunogenic cells, and associated methods and compositions
US11459372B2 (en) 2020-11-30 2022-10-04 Crispr Therapeutics Ag Gene-edited natural killer cells
WO2022125439A2 (en) * 2020-12-07 2022-06-16 The Regents Of The University Of California Innate immune cell silencing by sirp-alpha engager
WO2022144632A1 (en) 2020-12-30 2022-07-07 Crispr Therapeutics Ag Compositions and methods for differentiating stem cells into nk cells
JP2024501971A (ja) 2020-12-31 2024-01-17 サナ バイオテクノロジー，インコーポレイテッド Ｃａｒ－ｔ活性を調節するための方法及び組成物
WO2022187379A1 (en) 2021-03-03 2022-09-09 Sana Biotechnology, Inc. Immunosuppressive therapies for use with cardiomyocyte cell therapies, and associated methods and compositions
US20240226164A1 (en) 2021-05-27 2024-07-11 Sana Biotechnology, Inc. Hypoimmunogenic cells comprising engineered hla-e or hla-g
KR20240046319A (ko) 2021-07-14 2024-04-08 사나 바이오테크놀로지, 인크. 저면역원성 세포에서의 y 염색체-연결 항원의 변경된 발현
AU2022327174A1 (en) 2021-08-11 2024-02-15 Sana Biotechnology, Inc. Inducible systems for altering gene expression in hypoimmunogenic cells
JP2024535677A (ja) 2021-08-11 2024-10-02 サナ バイオテクノロジー，インコーポレイテッド 即時血液媒介性炎症反応を減少させるための同種細胞療法を目的とした遺伝子改変細胞
EP4384598A1 (en) 2021-08-11 2024-06-19 Sana Biotechnology, Inc. Genetically modified cells for allogeneic cell therapy to reduce complement-mediated inflammatory reactions
US20240358761A1 (en) 2021-08-11 2024-10-31 Sana Biotechnology, Inc. Genetically modified cells for allogeneic cell therapy
AU2022325232A1 (en) 2021-08-11 2024-02-08 Sana Biotechnology, Inc. Genetically modified primary cells for allogeneic cell therapy
CN118159646A (zh) * 2021-09-13 2024-06-07 富士胶片细胞动力公司 产生定向心脏祖细胞的方法
WO2023047433A1 (en) * 2021-09-23 2023-03-30 The University Of Jordan Dental pluripotent stem cells
CN115873797B (zh) * 2021-09-29 2024-08-13 北京干细胞与再生医学研究院 一种视网膜色素上皮细胞的扩增培养基及培养方法
WO2023069480A1 (en) * 2021-10-20 2023-04-27 Vascugen, Inc. Hypoimmune vasculogenic cells
CN119072319A (zh) 2021-12-23 2024-12-03 萨那生物技术股份有限公司 用于治疗自身免疫性疾病的嵌合抗原受体(car)t细胞及相关方法
KR20240142624A (ko) * 2022-01-10 2024-09-30 사나 바이오테크놀로지, 인크. 만능줄기세포에서 분화된 면역저하 베타세포 및 관련 용도 및 방법
US20250302953A1 (en) 2022-02-14 2025-10-02 Sana Biotechnology, Inc. Methods of treating patients exhibiting a prior failed therapy with hypoimmunogenic cells
EP4479416A1 (en) 2022-02-17 2024-12-25 Sana Biotechnology, Inc. Engineered cd47 proteins and uses thereof
WO2023173123A1 (en) 2022-03-11 2023-09-14 Sana Biotechnology, Inc. Genetically modified cells and compositions and uses thereof
WO2023183313A1 (en) 2022-03-22 2023-09-28 Sana Biotechnology, Inc. Engineering cells with a transgene in b2m or ciita locus and associated compositions and methods
CN116804185A (zh) 2022-03-25 2023-09-26 士泽生物医药（苏州）有限公司 一种通用型细胞及其制备方法
KR20250008812A (ko) * 2022-04-07 2025-01-15 페이트 세러퓨틱스, 인코포레이티드 동종 세포 치료에 사용하기 위한 면역 인식 경로에 관여하는 스텔스 전략
CN114958768B (zh) * 2022-06-02 2023-03-24 健颐生物科技发展(山东)有限公司 Fgf10旁分泌通用型人成纤维细胞制剂的制备方法
US20260002124A1 (en) 2022-07-01 2026-01-01 Novo Nordisk A/S Enhancing neuronal differentiation of ventral midbrain neural progenitor cells
WO2024030959A1 (en) 2022-08-02 2024-02-08 Sana Biotechnology, Inc. Methods for differentiating cardiomyocytes
WO2024050349A2 (en) * 2022-08-30 2024-03-07 Emendobio Inc. Strategies for knock-ins at b2m safe harbor sites
JP2026500455A (ja) * 2022-10-25 2026-01-07 ウィスコンシン アルムニ リサーチ ファンデイション 幹細胞治療のための接着分子阻害
EP4633658A1 (en) * 2022-12-12 2025-10-22 Proletariat Therapeutics, Inc. Methods of treating cardiac injury
GB202218755D0 (en) * 2022-12-13 2023-01-25 Replay Holdings Llc Compositions and methods for non-immunogenicity
WO2024151541A1 (en) 2023-01-09 2024-07-18 Sana Biotechnology, Inc. Type-1 diabetes autoimmune mouse
AU2024264889A1 (en) 2023-05-03 2025-11-13 Sana Biotechnology, Inc. Methods of dosing and administration of engineered islet cells
EP4716541A2 (en) 2023-05-22 2026-04-01 Sana Biotechnology, Inc. Methods of delivery of islet cells and related methods
US12565639B2 (en) 2023-06-13 2026-03-03 Aspen Neuroscience, Inc. Methods for differentiating dopaminergic neurons from stem cells
EP4735585A1 (en) 2023-06-30 2026-05-06 Novo Nordisk A/S Enhancing neuronal differentiation of neural progenitor cells
KR102740042B1 (ko) * 2023-07-12 2024-12-06 ㈜바이오솔빅스 인간 전분화능 줄기세포로 유래된 심장 오가노이드 제조방법, 효능 및 독성 평가 기술
IL326274A (en) * 2023-08-02 2026-04-01 Fate Therapeutics Inc A targeted scaffold for solid tumors that promotes effector cell differentiation and function
WO2025043172A1 (en) 2023-08-23 2025-02-27 Sana Biotechnology, Inc. Modified cd47 proteins and their uses
WO2025047921A1 (ja) * 2023-09-01 2025-03-06 株式会社セル―ジョン 拒絶反応に対する回避方法
WO2025054202A1 (en) 2023-09-05 2025-03-13 Sana Biotechnology, Inc. Method of screening a sample comprising a transgene with a unique barcode
WO2025075929A1 (en) * 2023-10-02 2025-04-10 Neurona Therapeutics Inc. Methods of treating seizure activity
WO2025096757A1 (en) 2023-11-01 2025-05-08 Sana Biotechnology, Inc. Hypoimmunogenic cd22-targeted car t cells for the treatment of relapsed and/or refractory b cell lymphomas
WO2025151838A1 (en) 2024-01-12 2025-07-17 Sana Biotechnology, Inc. Safety switches to control in vitro and in vivo proliferation of cell therapy products
CN117919504B (zh) * 2024-01-29 2024-12-20 山东第一医科大学附属省立医院(山东省立医院) 一种ros响应微纳结构钛植入物纳米涂层及其制备方法与应用
CN118345030B (zh) * 2024-06-20 2024-08-16 羽铂精制生物技术(成都)有限公司 iPSC诱导分化成为胰腺祖细胞修复胰腺的方法及应用
CN119464205A (zh) * 2025-01-16 2025-02-18 北京大学第三医院（北京大学第三临床医学院） 干细胞来源的功能增强型间充质基质细胞及其制备方法和应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001011011A2 (en) * 1999-08-05 2001-02-15 Mcl Llc Multipotent adult stem cells and methods for isolation
US8491883B2 (en) * 2003-06-27 2013-07-23 Advanced Technologies And Regenerative Medicine, Llc Treatment of amyotrophic lateral sclerosis using umbilical derived cells
WO2006071778A2 (en) * 2004-12-23 2006-07-06 Ethicon Incorporated Treatment of parkinson's disease and related disorders using postpartum derived cells
CA2771336C (en) * 2009-09-15 2019-11-26 The Board Of Trustees Of The Leland Stanford Junior University Synergistic anti-cd47 therapy for hematologic cancers
WO2011130675A2 (en) * 2010-04-16 2011-10-20 The Mclean Hospital Corporation Dopaminergic neurons differentiated from pluripotent stem cells and uses of thereof
WO2014078414A1 (en) * 2012-11-13 2014-05-22 Joseph Wu Chemically defined production of cardiomyocytes from pluripotent stem cells
AU2014248167B2 (en) * 2013-04-03 2019-10-10 FUJIFILM Cellular Dynamics, Inc. Methods and compositions for culturing endoderm progenitor cells in suspension
KR101696874B1 (ko) * 2013-07-31 2017-01-16 한국생명공학연구원 직접 리프로그래밍을 통한 유도 도파민성 전구세포 제조방법
WO2015042356A1 (en) * 2013-09-19 2015-03-26 The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Chemically defined culture medium for stem cell maintenance and differentiation
US20180243343A1 (en) * 2015-02-26 2018-08-30 The Mclean Hospital Corporation Methods and compositions for the treatment or prevention of parkinson's disease
CN107921148A (zh) * 2015-05-08 2018-04-17 哈佛学院校长同事会 通用供体干细胞和相关方法
EP3344758B1 (en) * 2015-09-01 2021-09-29 Ncardia B.V. An in vitro method of differentiating a human pluripotent stem cell population into a cardiomyocyte cell population
KR20250141836A (ko) * 2015-11-04 2025-09-29 페이트 세러퓨틱스, 인코포레이티드 만능 세포의 유전자 조작
JP2020505025A (ja) * 2017-01-13 2020-02-20 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 免疫工学的な改変をした多能性細胞
CN108048484B (zh) * 2017-11-14 2021-07-06 海南一龄医疗产业发展有限公司 诱导性多能干细胞及其制备方法和应用
CA3109078A1 (en) * 2018-07-17 2020-01-23 The Regents Of The University Of California Cells differentiated from immunoengineered pluripotent cells
KR20220158046A (ko) * 2020-03-25 2022-11-29 사나 바이오테크놀로지, 인크. 신경계 장애 및 병태의 치료를 위한 면역저하성 신경 세포

Similar Documents

Publication Publication Date Title
JP2021530232A5 (https=)
Rosenblatt-Velin et al. FGF-2 controls the differentiation of resident cardiac precursors into functional cardiomyocytes
Sahara et al. Programming and reprogramming a human heart cell
Tang et al. Reprogramming liver-stem WB cells into functional insulin-producing cells by persistent expression of Pdx1-and Pdx1-VP16 mediated by lentiviral vectors
Tomescot et al. Differentiation in vivo of cardiac committed human embryonic stem cells in postmyocardial infarcted rats
US9932558B2 (en) Compositions and methods for obtaining cells to treat heart tissue
Mathison et al. In vivo cardiac cellular reprogramming efficacy is enhanced by angiogenic preconditioning of the infarcted myocardium with vascular endothelial growth factor
Hong et al. Cardiac stem cell therapy for cardiac repair
US11015211B2 (en) Cardiac cell reprogramming with myocardin and ASCL1
JP2021530232A (ja) 免疫改変された多能性細胞から分化させた細胞
Riching et al. Cardiac regeneration: new insights into the frontier of ischemic heart failure therapy
US20060281791A1 (en) Methods of increasing proliferation of adult mammalian cardiomyocytes through p38 map kinase inhibition
Yamada et al. Development of direct cardiac reprogramming for clinical applications
Cianflone et al. The negative regulation of gene expression by microRNAs as key driver of inducers and repressors of cardiomyocyte differentiation
Singla et al. Enhancement by growth factors of cardiac myocyte differentiation from embryonic stem cells: a promising foundation for cardiac regeneration
US20230137971A1 (en) Cardiac cell reprogramming with micrornas and other factors
EP3431593A1 (en) Method for directly producing cardiac precursor cell or myocardial cell from fibroblast
Yanase et al. Differentiation and regeneration of adrenal tissues: an initial step toward regeneration therapy for steroid insufficiency
JP2025065482A (ja) Ｍｙｃｌの一過性発現による増殖可能な膵島前駆細胞様細胞の誘導とインスリン陽性細胞への分化誘導
Xu et al. Role of GATA-4 in differentiation and survival of bone marrow mesenchymal stem cells
Jin et al. Advances in fibroblast-based cardiac reprogramming in the treatment of heart disease
Lou Tissue Engineered Cardiac Muscle Patches with Human Pluripotent Stem Cells Enhance the Repairing Efficacy of Infarcted Cardiac Muscle in Mouse Model
Lou Human Pluripotent Stem Cells and Patches Enhance the Repairing Efficacy of Infarcted Cardiac Muscle in Mouse Model
Zhou et al. Using the Existing Cardiac Cells
Tani et al. Heart Regeneration for Clinical Application